mazindol has been researched along with g(m1) ganglioside in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rothblat, DS; Schneider, JS | 1 |
Pope-Coleman, A; Schneider, JS; Tinker, JP | 1 |
2 other study(ies) available for mazindol and g(m1) ganglioside
Article | Year |
---|---|
Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.
Topics: Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Mazindol; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease, Secondary; Potassium | 1998 |
Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Binding Sites; Dopamine Agents; Dopamine Antagonists; Dopamine Uptake Inhibitors; G(M1) Ganglioside; Mazindol; Neostriatum; Parkinsonian Disorders; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Recovery of Function; Saimiri; Spiperone; Synapses | 2000 |